We are dedicated to increase treatment effects through new pharmaceutical formulations that are most patient-friendly.
With the growing elderly population, there is the need for more patient-friendly dosage forms, and OD!FS® will meet this need.
As our platform technologies have already been applied to various indications, we have seen commercial achievements with renowned domestic and international partners. We also own OD!FS® pipeline products that are currently in the clinical trial or research stages. Beyond these, we are planning to expand our business areas to new formulations that offer increased convenience of administration, such as pro-drugs and microbiome-based products.